Publications
Search in 13054 publications:
13054 Publication(s)
Self-reported neurocognitive impairment in people living with HIV: Characterizing clusters of patients with similar changes in self-reported neurocognitive impairment 2013-2017 in the Swiss HIV Cohort Study
Kusejko K, Kouyos R, Günthard H, Hauser C, Du Pasquier R, Schmid P, Cavassini M, Doco-Lecompte T, Bernasconi E, Tarr P, Braun D, Salazar-Vizcaya L, Swiss HIV Cohort Study. Self-reported neurocognitive impairment in people living with HIV: Characterizing clusters of patients with similar changes in self-reported neurocognitive impairment 2013-2017 in the Swiss HIV Cohort Study. Clin Infect Dis 2019
Sep 3, 2019Self-reported neurocognitive impairment in people living with HIV: Characterizing clusters of patients with similar changes in self-reported neurocognitive impairment 2013-2017 in the Swiss HIV Cohort Study
Sep 3, 2019Clin Infect Dis 2019
Kusejko Katharina, Kouyos Roger D, Günthard Huldrych F, Hauser Christoph, Du Pasquier Renaud, Schmid Patrick, Cavassini Matthias, Doco-Lecompte Thanh, Bernasconi Enos, Tarr Philip E, Braun Dominique L, Salazar-Vizcaya Luisa, Swiss HIV Cohort Study
ERCP in babies: Low risk of post-ERCP pancreatitis - results from a multicentre survey
Goetz M, Andersen P, Bergman J, Frei N, Schmidt A, Kähler G, Martus P, Dechêne A. ERCP in babies: Low risk of post-ERCP pancreatitis - results from a multicentre survey. United European Gastroenterol J 2019; 8:77-80.
Sep 3, 2019ERCP in babies: Low risk of post-ERCP pancreatitis - results from a multicentre survey
Sep 3, 2019United European Gastroenterol J 2019; 8:77-80
Goetz Martin, Andersen Philipp, Bergman Jacques, Frei Nicola Fabian, Schmidt Arthur, Kähler Georg, Martus Peter, Dechêne Alexander
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial
Iglesias J, Windecker S, Jüni P, Zwahlen M, Odutayo A, Valgimigli M, Eeckhout E, Losdat S, Stortecky S, Tapponnier M, Kaiser C, Weilenmann D, Moarof I, Kurz D, Roffi M, Heg D, Muller O, Pilgrim T. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Lancet 2019; 394:1243-1253.
Sep 2, 2019Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial
Sep 2, 2019Lancet 2019; 394:1243-1253
Iglesias Juan F, Windecker Stephan, Jüni Peter, Zwahlen Marcel, Odutayo Ayodele, Valgimigli Marco, Eeckhout Eric, Losdat Sylvain, Stortecky Stefan, Tapponnier Maxime, Kaiser Christoph, Weilenmann Daniel, Moarof Igal, Kurz David J, Roffi Marco, Heg Dik, Muller Olivier, Pilgrim Thomas
[Modern Treatment Concepts in Radiation Oncology]
Plasswilm L, Studer G, Aebersold D, Zwahlen D. [Modern Treatment Concepts in Radiation Oncology]. Ther Umsch 2019; 76:209-218.
Sep 1, 2019[Modern Treatment Concepts in Radiation Oncology]
Sep 1, 2019Ther Umsch 2019; 76:209-218
Plasswilm Ludwig, Studer Gabriela, Aebersold Daniel M, Zwahlen Daniel R
State-of-the-Art Report: Visual Computing in Radiation Therapy Planning
Schlachter M, Raidou R, Muren L, Preim B, Putora P, Bühler K. State-of-the-Art Report: Visual Computing in Radiation Therapy Planning. Computer Graphics Forum 2019:753-779.
Sep 1, 2019State-of-the-Art Report: Visual Computing in Radiation Therapy Planning
Sep 1, 2019Computer Graphics Forum 2019:753-779
Schlachter M, Raidou R.G., Muren L.P., Preim B., Putora Paul Martin, Bühler K.
Long Term Evaluation Should Be an Integral Part of the Clinical Implementation of New Vascular Treatments - an ESVS Executive Committee Position Statement
Sillesen H, Vikatmaa P, Verhagen H, Jongkind V, Haulon S, Halliday A, Eiberg J, Dick F, Debus S, Kolh P. Long Term Evaluation Should Be an Integral Part of the Clinical Implementation of New Vascular Treatments - an ESVS Executive Committee Position Statement. Eur J Vasc Endovasc Surg 2019; 58:315-317.
Sep 1, 2019Long Term Evaluation Should Be an Integral Part of the Clinical Implementation of New Vascular Treatments - an ESVS Executive Committee Position Statement
Sep 1, 2019Eur J Vasc Endovasc Surg 2019; 58:315-317
Sillesen Henrik, Vikatmaa Pirkka, Verhagen Hence, Jongkind Vincent, Haulon Stephan, Halliday Alison, Eiberg Jonas, Dick Florian, Debus Sebastian, Kolh Philippe
Suspension Technique for Unstable Nasal Bones
Tasman A. Suspension Technique for Unstable Nasal Bones. JAMA Facial Plast Surg 2019; 21:460.
Sep 1, 2019Suspension Technique for Unstable Nasal Bones
Sep 1, 2019JAMA Facial Plast Surg 2019; 21:460
Tasman Abel-Jan
EJVES, the Leading Journal in Vascular Surgery, is One of the Numerous Scientific Pillars of the ESVS
Kolh P, Dick F, Sillesen H. EJVES, the Leading Journal in Vascular Surgery, is One of the Numerous Scientific Pillars of the ESVS. Eur J Vasc Endovasc Surg 2019; 58:311-314.
Sep 1, 2019EJVES, the Leading Journal in Vascular Surgery, is One of the Numerous Scientific Pillars of the ESVS
Sep 1, 2019Eur J Vasc Endovasc Surg 2019; 58:311-314
Kolh Philippe, Dick Florian, Sillesen Henrik
[Molecularly-targeted anticancer treatments - a short appraisal]
Jörger M. [Molecularly-targeted anticancer treatments - a short appraisal]. Ther Umsch 2019; 76:179-185.
Sep 1, 2019[Molecularly-targeted anticancer treatments - a short appraisal]
Sep 1, 2019Ther Umsch 2019; 76:179-185
Jörger Markus
End-to-End testing method for SRS patient QA based on a new multidetector array and comparison with two other techniques
Buchauer K, Socoliuctoquant A, Plasswilm L, Schiefer J (2019). End-to-End testing method for SRS patient QA based on a new multidetector array and comparison with two other techniques.
Aug 31, 2019End-to-End testing method for SRS patient QA based on a new multidetector array and comparison with two other techniques
Aug 31, 2019SASRO 2019
Buchauer Konrad, Socoliuctoquant A, Plasswilm Ludwig, Schiefer Johann
Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland - a systematic review
Fulchini R, Albrich W, Kronenberg A, Egli A, Kahlert C, Schlegel M, Kohler P. Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland - a systematic review. Epidemiol Infect 2019; 147:e259.
Aug 30, 2019Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland - a systematic review
Aug 30, 2019Epidemiol Infect 2019; 147:e259
Fulchini R, Albrich Werner, Kronenberg A, Egli A, Kahlert Christian, Schlegel Matthias, Kohler Philipp
A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors
Jörger M, Sessa C, Stuedeli S, Levy N, Hafner P, Lane H, Larger P, Engelhardt M, Kaindl T, Volden M, Mark M, Mantiero M, Hess D, Metaxas Y, Stathis A, von Moos R. A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors. Invest New Drugs 2019
Aug 30, 2019A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors
Aug 30, 2019Invest New Drugs 2019
Jörger Markus, Sessa Cristiana, Stuedeli Silvia, Levy Nicole, Hafner Peter, Lane Heidi, Larger Patrice, Engelhardt Marc, Kaindl Thomas, Volden Matthias, Mark Michael, Mantiero Mara, Hess Dagmar, Metaxas Yannis, Stathis Anastasios, von Moos Roger
Evolving Strategies for Resection of Sellar/Parasellar Synchronous Tumors via Endoscopic Endonasal Approach: A Technical Case Report and Systematic Review of the Literature.
Roethlisberger M, Jayapalan R, Hostettler I, Bin Abd Kadir K, Mun K, Brand Y, Mariani L, Prepageran N, Waran V. Evolving Strategies for Resection of Sellar/Parasellar Synchronous Tumors via Endoscopic Endonasal Approach: A Technical Case Report and Systematic Review of the Literature. World Neurosurg 2019; 133:381-391.e2.
Aug 30, 2019Evolving Strategies for Resection of Sellar/Parasellar Synchronous Tumors via Endoscopic Endonasal Approach: A Technical Case Report and Systematic Review of the Literature.
Aug 30, 2019World Neurosurg 2019; 133:381-391.e2
Roethlisberger Michel, Jayapalan Ronie Romelean, Hostettler Isabel, Bin Abd Kadir Khairul Azmi, Mun Kein Seong, Brand Yves, Mariani Luigi, Prepageran Narayanan, Waran Vicknes
Response to: neurosurgical procedures performed during residency in Europe-preliminary numbers and time trends
Stienen M, Schaller K, Regli L, Ringel F, Demetriades A, Schubert G, Adib S, Samprón N, Renovanz M, Moojen W, Krieg S, Kolias A, Freyschlag C, Czabanka M, Bartek J, Meling T. Response to: neurosurgical procedures performed during residency in Europe-preliminary numbers and time trends. Acta Neurochir (Wien) 2019; 161:1977-1979.
Aug 29, 2019Response to: neurosurgical procedures performed during residency in Europe-preliminary numbers and time trends
Aug 29, 2019Acta Neurochir (Wien) 2019; 161:1977-1979
Stienen Martin N., Schaller Karl, Regli Luca, Ringel Florian, Demetriades Andreas K, Schubert Gerrit A, Adib Sasan D, Samprón Nicolás, Renovanz Mirjam, Moojen Wouter, Krieg Sandro M, Kolias Angelos, Freyschlag Christian F, Czabanka Marcus A, Bartek Jiri, Meling Torstein R
Chest X-ray Dose Equivalent Low-dose CT with Tin Filtration: Potential Role for the Assessment of Pectus Excavatum
Messerli-Odermatt O, Serrallach B, Gubser M, Leschka S, Bauer R, Dubois J, Alkadhi H, Wildermuth S, Wälti S. Chest X-ray Dose Equivalent Low-dose CT with Tin Filtration: Potential Role for the Assessment of Pectus Excavatum. Acad Radiol 2019; 27:644-650.
Aug 28, 2019Chest X-ray Dose Equivalent Low-dose CT with Tin Filtration: Potential Role for the Assessment of Pectus Excavatum
Aug 28, 2019Acad Radiol 2019; 27:644-650
Messerli-Odermatt Olivia, Serrallach Bettina, Gubser Manuel, Leschka Sebastian, Bauer Ralf, Dubois Josée, Alkadhi Hatem, Wildermuth Simon, Wälti Stephan
Prediction of short- and long-term mortality in takotsubo syndrome: the InterTAK Prognostic Score
Lairez O, Hauck C, Paolini C, Bilato C, Prasad A, Rihal C, Liu K, Schulze P, Bianco M, Jörg L, Rickli H, Carrilho-Ferreira P, Poglajen G, El-Battrawy I, Akin I, Gilyarova E, Shilova A, Gilyarov M, Kozel M, Tousek P, Winchester D, Galuszka J, Ukena C, Nguyen T, Kobayashi Y, Böhm M, Bauersachs J, Katus H, Horowitz J, di Mario C, Münzel T, Crea F, Bax J, Lüscher T, Ruschitzka F, Ghadri J, Thiele H, Schunkert H, Maier L, Pinto F, Widimsky P, Borggrefe M, Felix S, Opolski G, Braun-Dullaeus R, Rottbauer W, Hasenfuß G, Pieske B, Templin C, Delmas C, Wischnewsky M, Sorici-Barb I, Jaguszewski M, Noutsias M, Knorr M, Heiner S, Burgdorf C, Kherad B, Tschope C, Sarcon A, Shinbane J, Franke J, Neuhaus M, Candreva A, Bacchi B, Cammann V, Kato K, Szawan K, Gili S, D'Ascenzo F, Dichtl W, Citro R, Bossone E, Rajan L, Michels G, Pfister R, Airaksinen K, Napp L, Budnik M, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Chan C, Bridgman P, Vasankari T, Fischer T, Cuneo A, Jacobshagen C, Karakas M, Koenig W, Pott A, Meyer P, Arroja J, Banning A, Cuculi F, Kobza R, Beug D. Prediction of short- and long-term mortality in takotsubo syndrome: the InterTAK Prognostic Score. Eur J Heart Fail 2019; 21:1469-1472.
Aug 27, 2019Prediction of short- and long-term mortality in takotsubo syndrome: the InterTAK Prognostic Score
Aug 27, 2019Eur J Heart Fail 2019; 21:1469-1472
Lairez Olivier, Hauck Christian, Paolini Carla, Bilato Claudio, Prasad Abhiram, Rihal Charanjit S, Liu Kan, Schulze P Christian, Bianco Matteo, Jörg Lucas, Rickli Hans, Carrilho-Ferreira Pedro, Poglajen Gregor, El-Battrawy Ibrahim, Akin Ibrahim, Gilyarova Ekaterina, Shilova Alexandra, Gilyarov Mikhail, Kozel Martin, Tousek Petr, Winchester David E, Galuszka Jan, Ukena Christian, Nguyen Thanh H, Kobayashi Yoshio, Böhm Michael, Bauersachs Johann, Katus Hugo A, Horowitz John, di Mario Carlo, Münzel Thomas, Crea Filippo, Bax Jeroen J, Lüscher Thomas F, Ruschitzka Frank, Ghadri Jelena R, Thiele Holger, Schunkert Heribert, Maier Lars S, Pinto Fausto J, Widimsky Petr, Borggrefe Martin, Felix Stephan B, Opolski Grzegorz, Braun-Dullaeus Ruediger C, Rottbauer Wolfgang, Hasenfuß Gerd, Pieske Burkert M, Templin Christian, Delmas Clément, Wischnewsky Manfred B, Sorici-Barb Ioana, Jaguszewski Milosz, Noutsias Michel, Knorr Maike, Heiner Susanne, Burgdorf Christof, Kherad Behrouz, Tschope Carsten, Sarcon Annahita, Shinbane Jerold, Franke Jennifer, Neuhaus Michael, Candreva Alessandro, Bacchi Beatrice, Cammann Victoria L, Kato Ken, Szawan Konrad A, Gili Sebastiano, D'Ascenzo Fabrizio, Dichtl Wolfgang, Citro Rodolfo, Bossone Eduardo, Rajan Lawrence, Michels Guido, Pfister Roman, Airaksinen K E Juhani, Napp L Christian, Budnik Monika, Dworakowski Rafal, MacCarthy Philip, Kaiser Christoph, Osswald Stefan, Galiuto Leonarda, Chan Christina, Bridgman Paul, Vasankari Tuija, Fischer Thomas A, Cuneo Alessandro, Jacobshagen Claudius, Karakas Mahir, Koenig Wolfgang, Pott Alexander, Meyer Philippe, Arroja Jose David, Banning Adrian, Cuculi Florim, Kobza Richard, Beug Daniel
Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
Hitz F, Driessen C, Mey U, Samaras P, Vilei S, Stüdeli S, Rondeau S, Seipel K, Novak U, Silzle T, Besse L, Hess D, Pabst T, Kraus M, Swiss Group for Clinical Cancer Research SAKK. Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10). Blood Cancer J 2019; 9:70.
Aug 27, 2019Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
Aug 27, 2019Blood Cancer J 2019; 9:70
Hitz Felicitas, Driessen Christoph, Mey U, Samaras P, Vilei S Berardi, Stüdeli S, Rondeau S, Seipel K, Novak U, Silzle Tobias, Besse Lenka, Hess Dagmar, Pabst T, Kraus Marianne, Swiss Group for Clinical Cancer Research SAKK
Developing a rare disease chronic care model: Management of systemic sclerosis (MANOSS) study protocol
Kocher A, Simon M, Dwyer A, Villiger P, Künzler-Heule P, De Geest S, Berben L, Nicca D. Developing a rare disease chronic care model: Management of systemic sclerosis (MANOSS) study protocol. J Adv Nurs 2019
Aug 26, 2019Developing a rare disease chronic care model: Management of systemic sclerosis (MANOSS) study protocol
Aug 26, 2019J Adv Nurs 2019
Kocher Agnes, Simon Michael, Dwyer Andrew A, Villiger Peter M, Künzler-Heule Patrizia, De Geest Sabina, Berben Lut, Nicca Dunja
Corrigendum to Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone? Growth Hormone & IGF Research 45 (2019) 20-24
Sze L, Tschopp O, Neidert M, Bernays R, Ghirlanda C, Zwimpfer C, Wiesli P, Schmid C. Corrigendum to Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone? Growth Hormone & IGF Research 45 (2019) 20-24. Growth Horm IGF Res 2019; 51:77.
Aug 26, 2019Corrigendum to Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone? Growth Hormone & IGF Research 45 (2019) 20-24
Aug 26, 2019Growth Horm IGF Res 2019; 51:77
Sze Lisa, Tschopp Oliver, Neidert Marian Christoph, Bernays René L, Ghirlanda Claudia, Zwimpfer Cornelia, Wiesli Peter, Schmid Christoph
Is it really IBS? Ovarian carcinoma
Hornung R (2019). Is it really IBS? Ovarian carcinoma. Presented at: 2nd Neuro Gastro Day Switzerland - The Neuro Gastro Motility Network (Swiss NGM), Universitätsspital Zürich
Aug 24, 2019Is it really IBS? Ovarian carcinoma
Aug 24, 20192nd Neuro Gastro Day Switzerland - The Neuro Gastro Motility Network (Swiss NGM)
Hornung René